How to Get GLP-1 Medications Covered Through Your Employer's Health Plan

Disclaimer: Insurance and cost information changes frequently. Always verify current coverage details with your insurer and prescriber.

First: Check Your Current Benefits

Before doing anything else, you need to understand what your current employer health plan actually covers. This sounds obvious, but the majority of employees have never read their Summary Plan Description (SPD) — the legally required document that outlines exactly what your plan covers, what it excludes, and the rules for accessing benefits. This document is your starting point.

Request your SPD from your HR department if you do not already have it. Once you have it, search for keywords like "obesity," "weight loss," "GLP-1," "semaglutide," "tirzepatide," and "anti-obesity medication." Some plans explicitly cover FDA-approved weight-loss medications. Others explicitly exclude them. Many fall somewhere in the middle — covering GLP-1s for diabetes but not for obesity, or requiring prior authorization with specific BMI and comorbidity criteria.

In parallel, look up your plan's drug formulary. Most large employer plans use a pharmacy benefits manager (PBM) — typically CVS Caremark, Express Scripts, or OptumRx. Your insurance card will tell you which PBM administers your drug benefits, and you can search the formulary on their website using your drug name. The tier level tells you how much the plan negotiates on cost; a drug not on the formulary at all signals a likely coverage exclusion.

Self-Insured vs. Fully Insured Plans: Why It Matters

The single most important variable in whether your employer can offer GLP-1 coverage is whether your plan is self-insured or fully insured. This distinction drives everything that follows.

A fully insured plan is one where your employer pays premiums to a commercial insurance company (like Aetna, Cigna, or UnitedHealthcare), and that insurer takes on the financial risk and determines what is covered. The insurer's coverage policies apply, and your employer has limited ability to customize them. If the insurance company excludes GLP-1s for obesity, your employer generally cannot simply "add" that coverage.

A self-insured (or self-funded) plan is one where your employer bears the financial risk directly — they pay claims themselves, often using the insurance company merely as an administrator (known as an Administrative Services Only, or ASO, arrangement). Self-insured plans are governed by ERISA, a federal law, rather than state insurance regulations. This means self-insured employers have broad discretion to define their benefits however they choose, including adding or removing GLP-1 coverage.

The majority of employees at large companies work for employers with self-insured plans. According to KFF data, about 65% of covered workers are enrolled in self-insured plans, and that number rises above 80% for employers with more than 200 employees. Companies like Amazon, Microsoft, JPMorgan Chase, and many others that have added GLP-1 coverage in recent years were all able to do so precisely because they are self-insured.

If your employer is self-insured and does not currently cover GLP-1s, the decision to add coverage rests entirely with your employer's benefits team — not with an outside insurer. That means employee advocacy and well-framed conversations with HR can actually move the needle.

How to Talk to Your HR Department

Many employees are reluctant to raise health coverage gaps with HR for fear of stigma or privacy concerns. These fears are understandable but should not stop you from advocating for yourself. Under HIPAA, your medical information is protected, and HR staff are trained to handle benefits inquiries confidentially.

Approach the conversation as a policy question rather than a personal medical disclosure. You can ask: "Does our health plan currently cover GLP-1 medications like Ozempic or Wegovy for weight management? If not, is this something being considered for future plan years?" This keeps the conversation at the level of plan benefits rather than your personal health.

If your company is large enough to have a benefits committee or an employee benefits advisory group, find out how to engage with it. Many large employers actively solicit employee feedback on benefits during annual planning cycles. A clear, data-backed case for adding GLP-1 coverage — citing productivity benefits, reduced long-term healthcare costs from preventing cardiovascular disease and diabetes complications, and the competitive landscape of peer companies already offering this benefit — can be persuasive.

Frame it as an investment, not just a cost. Studies, including published actuarial analyses, suggest that the downstream savings from reduced cardiovascular events, hospitalizations, and diabetes progression in GLP-1 users can offset a significant portion of the medication cost within three to five years. HR professionals and CFOs respond to this framing.

Documenting Medical Necessity

If your plan covers GLP-1 medications but requires prior authorization, the documentation your prescriber provides is often the determining factor in approval or denial. Work closely with your doctor to ensure the prior authorization request is comprehensive and well-supported.

A strong prior authorization package typically includes: your current BMI and documented weight history, any weight-related comorbidities (hypertension, pre-diabetes, Type 2 diabetes, sleep apnea, elevated lipids, osteoarthritis), documentation of prior weight-loss attempts (diet programs, lifestyle interventions, other medications), and a physician letter of medical necessity that specifically addresses why pharmacological intervention is medically indicated for you.

The letter of medical necessity is particularly powerful when it goes beyond the basics. Ask your prescriber to mention any cardiovascular risk factors, the SELECT trial data showing that semaglutide reduces major adverse cardiovascular events by 20% in obese patients without diabetes, and the specific clinical guidelines (AHA, ACC, Obesity Medicine Association) that recommend pharmacotherapy for patients at your BMI and risk profile. A well-written letter transforms a routine prior auth into a clinical argument that is much harder to deny.

Using Open Enrollment to Your Advantage

If your current plan does not cover GLP-1 medications, your employer's open enrollment period is your annual opportunity to select a plan that might. If your employer offers multiple plan options — a common feature at larger companies — compare formularies carefully before selecting.

Request the formulary documents for each available plan during the enrollment window. Plans that work with certain PBMs or that have negotiated a specific benefit package may include GLP-1 coverage while others do not. In some cases, a plan with a higher premium but GLP-1 coverage may be far more cost-effective than a lower-premium plan that leaves you paying $900+ per month out of pocket.

Health Savings Accounts (HSAs) paired with high-deductible health plans are another tool worth considering. HSA funds can be used for prescription drug costs tax-free, effectively giving you a discount equal to your marginal tax rate on medication costs. If you contribute the maximum to your HSA ($4,150 for individuals, $8,300 for families in 2024), you can use those funds to cover GLP-1 costs while the account accumulates tax-free.

What to Do If Your Claim Is Denied

An initial denial is not the end of the road. Under ERISA, you have the right to appeal any adverse benefit determination made by an employer-sponsored health plan. The plan must provide you with a written explanation of the denial, the specific plan provisions that support the denial, and the information needed to perfect your appeal.

The internal appeals process typically allows you 180 days to submit an appeal after receiving a denial. Your appeal should include your physician's letter of medical necessity, relevant clinical guidelines supporting treatment, any peer-reviewed literature on GLP-1 efficacy and safety, and a clear rebuttal of the specific reason cited for the denial. Address their stated rationale point by point.

If your internal appeal is denied, ERISA plans are required to offer access to an external review by an Independent Review Organization (IRO) for clinical matters. External appeals are decided by medical professionals with no financial stake in the outcome, and reversal rates for well-documented medical necessity cases are meaningful — typically 30–50% of external appeals result in the original denial being overturned. Do not skip this step.

Your prescriber can also request a peer-to-peer review, which is a direct conversation between your doctor and the insurance company's medical director. This is one of the highest-yield interventions available — a physician speaking directly to another physician about your clinical case is far more persuasive than paperwork alone. Ask your prescriber's office if they offer this service, as many practices now have staff who handle prior auth and appeals as a routine part of their workflow.